Literature DB >> 8319160

Astemizole. A nonsedating antihistamine with fast and sustained activity.

M M Janssens1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8319160     DOI： 10.1007/BF02802293

Source DB:  PubMed          Journal:  Clin Rev Allergy        ISSN： 0731-8235


× No keyword cloud information.
  57 in total

1.  Onset and duration of the effects of three antihistamines in current use--astemizole, loratadine and terfenadine forte--studied during prolonged, controlled allergen challenges in volunteers.

Authors:  F Horak; S Jäger; U Berger
Journal:  J Int Med Res       Date:  1992-09       Impact factor: 1.671

2.  The effects of astemizole, cetirizine and loratadine on the time course of weal and flare reactions to histamine, codeine and antigen.

Authors:  F Humphreys; J A Hunter
Journal:  Br J Dermatol       Date:  1991-10       Impact factor: 9.302

Review 3.  The role of antihistamines in atopic dermatitis.

Authors:  J M Hanifin
Journal:  J Allergy Clin Immunol       Date:  1990-10       Impact factor: 10.793

4.  Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome.

Authors:  R A Freedman; K P Anderson; L S Green; J W Mason
Journal:  Am J Cardiol       Date:  1987-01-01       Impact factor: 2.778

5.  Astemizole. Its use in the treatment of patients with chronic vertigo.

Authors:  R T Jackson; J S Turner
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1987-05

6.  Effect of the nonsedative H1-receptor antagonist astemizole in perennial allergic and nonallergic rhinitis.

Authors:  J A Wihl; B N Petersen; L N Petersen; G Gundersen; K Bresson; N Mygind
Journal:  J Allergy Clin Immunol       Date:  1985-06       Impact factor: 10.793

7.  Efficacy of continuous treatment with astemizole (Hismanal) and terfenadine (Seldane) in ragweed pollen-induced rhinoconjunctivitis.

Authors:  E F Juniper; J White; J Dolovich
Journal:  J Allergy Clin Immunol       Date:  1988-10       Impact factor: 10.793

8.  Astemizole and cetirizine in the treatment of seasonal allergic rhinitis: a comparative double-blind, multicentre study.

Authors:  E Rijntjes; L Ghys; J P Rihoux
Journal:  J Int Med Res       Date:  1990 May-Jun       Impact factor: 1.671

Review 9.  Onset of action of astemizole.

Authors:  M M Janssens; L I Caers
Journal:  Int J Clin Pharmacol Res       Date:  1991

10.  Effects of azatadine, terfenadine, and astemizole on allergen-induced nasal provocation.

Authors:  P Small; D Barrett; N Biskin
Journal:  Ann Allergy       Date:  1990-02
View more
  5 in total

Review 1.  Pharmacokinetic-pharmacodynamic relationships of H1-antihistamines.

Authors:  J P Desager; Y Horsmans
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

Review 2.  Clinical pharmacology of new histamine H1 receptor antagonists.

Authors:  F E Simons; K J Simons
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

Review 3.  H1-receptor antagonists. Comparative tolerability and safety.

Authors:  F E Simons
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

4.  Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents.

Authors:  Yervand Eduard Karapetyan; Gian Franco Sferrazza; Minghai Zhou; Gregory Ottenberg; Timothy Spicer; Peter Chase; Mohammad Fallahi; Peter Hodder; Charles Weissmann; Corinne Ida Lasmézas
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-01       Impact factor: 11.205

5.  Astemizole Inhibits mTOR Signaling and Angiogenesis by Blocking Cholesterol Trafficking.

Authors:  Junfang Lyu; Eun Ju Yang; Sarah A Head; Nana Ai; Baoyuan Zhang; Changjie Wu; Ruo-Jing Li; Yifan Liu; Harapriya Chakravarty; Shaolin Zhang; Kin Yip Tam; Yongjun Dang; Ho Jeong Kwon; Wei Ge; Jun O Liu; Joong Sup Shim
Journal:  Int J Biol Sci       Date:  2018-06-23       Impact factor: 6.580
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.